Literature DB >> 14001722

Acute necrosis of adrenal cortex and corpora lutea induced by 7,12-dimethylbenzanthracene and its implication in carcinogenesis.

T W WONG, N E WARNER, N C YANG.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX DISEASES; BENZANTHRACENES; CORPUS LUTEUM; NECROSIS

Mesh：

Substances：

Year:  1962        PMID： 14001722

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  ARTERIAL LESIONS IN RATS FOLLOWING INJECTION OF 4'-FLUORO-10-METHYL-1,2-BENZANTHRACENE.

Authors:  J D TANGE; R G NEWMAN
Journal:  Am J Pathol       Date:  1963-11       Impact factor: 4.307

2.  DISTRIBUTION AND SPECIES LIMITATION OF THE ADRENAL LESIONS INDUCED BY 7,12-DIMETHYLBENZ(A)ANTHRACENE.

Authors:  F CEFIS; C M GOODALL
Journal:  Am J Pathol       Date:  1965-02       Impact factor: 4.307

3.  [COMPARATIVE STUDIES ON THE INDUCTION OF MAMMARY GLAND TUMORS IN WISTAR, SPRAGUE AND DAWLEY RATS BY THE ORAL ADMINISTRATION OF 7,12-DIMETHYL-1,2-BENZANTHRACENE].

Authors:  K ENGELBART; D GERICKE
Journal:  Z Krebsforsch       Date:  1964-11-02

4.  Adrenal lipid and plasma corticosterone depletion after 7,12-dimethylbenz (a) anthracene administration to the albino rat.

Authors:  E Dale; F D Schutchfield
Journal:  Experientia       Date:  1968-07-15

5.  Progesterone metabolism by adrenal homogenates of rats treated with 7, 12-dimethylbenz [A] anthracene.

Authors:  E Dale; F D Scutchfield
Journal:  Br J Exp Pathol       Date:  1969-04

6.  The effects of a single dose of 7,12-dimethylbenz(a)-anthracene on the epidermis and hair follicles of mice, with notes on concurrent changes in the ovaries and adrenals.

Authors:  B Bond; J W Orr
Journal:  Br J Cancer       Date:  1969-03       Impact factor: 7.640

7.  Effect of androgenisation on the development of mammary tumours in rats induced by the oral administration of 9,10-dimethyl-1,2-benzanthracene.

Authors:  K Kovács
Journal:  Br J Cancer       Date:  1965-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.